RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BBH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of VanEck Vectors Biotech ETF downgraded after the last trading session.
(Updated on Mar 28, 2024)

Buy or Hold candidate since Mar 27, 2024 Loss -0.41% PDF

The VanEck Vectors Biotech ETF price fell by -0.407% on the last day (Thursday, 28th Mar 2024) from $167.01 to $166.33. During the last trading day the ETF fluctuated 0.469% from a day low at $166.33 to a day high of $167.11. The price has been going up and down for this period, and there has been a 1.63% gain for the last 2 weeks. Volume has increased on the last day by 1 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 9 thousand shares were bought and sold for approximately $1.47 million.

The ETF lies the upper part of a falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $166.95 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the ETF is expected to fall -2.09% during the next 3 months and, with a 90% probability hold a price between $154.20 and $163.46 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BBH Signals & Forecast

There are mixed signals in the ETF today. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen -0.407%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). VanEck Vectors Biotech gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The VanEck Vectors Biotech ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $165.61 and $164.35. A breakdown below any of these levels will issue sell signals. The ETF had a Golden Star Signal on Monday, August 07, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.

Buy
Special Signal Notification

Golden Star 12 Months

The ETF had a Golden Star Signal on Monday, August 07, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.

Support, Risk & Stop-loss for VanEck Vectors Biotech ETF

VanEck Vectors Biotech finds support from accumulated volume at $166.27 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the ETF tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the ETF moved $0.780 between high and low, or 0.469%. For the last week the ETF has had daily average volatility of 0.607%.

Our recommended stop-loss: $161.15 (-3.11%) (This ETF has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (BBH) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect VanEck Vectors Biotech ETF to open at $166.59, and during the day (based on 14 day Average True Range), to move between $164.72 and $167.94, which gives a possible trading interval of +/-$1.61 (+/-0.97%) up or down from last closing price. If VanEck Vectors Biotech ETF takes out the full calculated possible swing range there will be an estimated 1.94% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $166.27 (0.04%) than the resistance at $167.99 (1.00%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is VanEck Vectors Biotech ETF ETF A Buy?

VanEck Vectors Biotech holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this ETF since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: -0.154 Hold/Accumulate Downgraded

Predicted Opening Price for VanEck Vectors Biotech ETF of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$166.59 ( 0.156%) $166.33

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BBH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 167.37 0.625 %
R2 167.07 0.446 %
R1 166.89 0.335 %
Current price: 166.33
Support S1 166.29 -0.0228 %
S2 166.11 -0.133 %
S3 165.81 -0.313 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 170.60 2.57 %
R2 169.33 1.80 %
R1 167.99 1.00 %
Current price 166.33
Support S1 166.27 -0.0361%
S2 166.15 -0.108%
S3 165.13 -0.721%

BBH Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Dec 15, 2023 Dec 18, 2023 Dec 22, 2023 $0.713 0.436%
2 Dec 16, 2022 Dec 19, 2022 Dec 23, 2022 $0.749 0.462%
3 Dec 17, 2021 Dec 20, 2021 Dec 27, 2021 $0.397 0.211%
4 Dec 18, 2020 Dec 21, 2020 Dec 28, 2020 $0.608 0.357%
5 Jan 16, 2019 Dec 23, 2019 Dec 30, 2019 $0.472 0.339%

FAQ

What is the symbol for VanEck Vectors Biotech ETF ETF and on which exchange is it traded?
The symbol for VanEck Vectors Biotech ETF is BBH and it is traded on the NYSEARCA (NYSE Arca).

Should I buy or sell VanEck Vectors Biotech ETF ETF?
VanEck Vectors Biotech holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this ETF since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy VanEck Vectors Biotech ETF ETF?
VanEck Vectors Biotech ETF ETF can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy VanEck Vectors Biotech ETF ETF.

What's the current price of VanEck Vectors Biotech ETF ETF?
As of the end of day on the 2024-03-28, the price of an VanEck Vectors Biotech ETF (BBH) share was $166.33.

What is the 52-week high and low for VanEck Vectors Biotech ETF ETF?
The 52-week high for VanEck Vectors Biotech ETF ETF is $171.05 and the 52-week low is $142.51.

What is the market capitalization of VanEck Vectors Biotech ETF ETF?
As of the 2024-03-28, the market capitalization of VanEck Vectors Biotech ETF is 454.979M.
Click to get the best stock tips daily for free!

About VanEck Vectors Biotech ETF

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capita... BBH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT